Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A New Anthrax Vaccine Administered by the Intramuscular (IM) Route in Healthy Adults

This study has been completed.
Information provided by:
DynPort Vaccine Company LLC, A CSC Company Identifier:
First received: April 3, 2003
Last updated: June 29, 2011
Last verified: June 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2004
  Primary Completion Date: April 2004 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):